1.
Vegh Z, Kurti Z, Lakatos PL. Epidemiology of inflammatory bowel diseases from west
to east. J Dig Dis. 2017;18:92-8.
2.Cui G, Yuan A. A Systematic Review of Epidemiology and Risk Factors Associated With
Chinese Inflammatory Bowel Disease. Front Med (Lausanne). 2018; 5: 183.
3.Yen HH, Weng MT, Tung CC, Wang YT, Chang YT, Chang CH, et al. Epidemiological trend
in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased
study. Intest Res 2019; 17: 54-62.
4.Mensink PB, Aktas H, Zelinkova Z, West RL, Kuipers EJ, van der Woude CJ. Impact of
double-balloon enteroscopy findings on the management of Crohn's disease. Scand J
Gastroenterol 2010; 45: 483-9.
5.
Chen H, Liu Y, Fu L, Lin X, Fan D, Li C. Clinical utility of double-balloon enteroscopy
in children: A single-centre experience in South China. J Paediatr Child Health 2019;
55: 188-93.
6.
Ye Z, Lin Y, Cao Q, He Y, Xue L. Granulomas as the Most Useful Histopathological Feature
in Distinguishing between Crohn's Disease and Intestinal Tuberculosis in Endoscopic
Biopsy Specimens. Medicine (Baltimore) 2015 doi: 10.1097/MD.0000000000002157.
7.Kedia S, Das P, Madhusudhan KS, Dattagupta S, Sharma R, Sahni P, et al. Differentiating
Crohn's disease from intestinal tuberculosis. World J Gastroenterol 2019; 25: 418-32.
8.
Gajendran M, Loganathan P, Catinella AP, Catinella AP, Ng N, Umapathy C, et al. A
comprehensive review and update on Crohn's disease. Dis Mon 2018; 64: 20-57.
9.
Kumarasinghe MP, Quek TP, Chau CY, Mustapha NR, Luman W, Ooi CJ. Endoscopic biopsy
features and diagnostic challenges of adult Crohn's disease at initial presentation.
Pathology 2010; 42: 131-7.
10.Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, et al. Early mucosal
changes in Crohn's disease. Gut 1993; 34: 375-81.
11.
Villanacci V, Antonelli E, Reboldi G, Salemme M, Casella G, Bassotti G. Endoscopic
biopsy samples of naive "colitides" patients: role of basal plasmacytosis. J Crohns
Colitis 2014; 8: 1438-43.
12.Sahn B, De Matos V, Stein R, Ruchelli E, Masur S, Klink AJ, et al. Histological features
of ileitis differentiating pediatric Crohn disease from ulcerative colitis with backwash
ileitis. Dig Liver Dis 2018; 50: 147-53.
13.
Geboes K, Van den Oord JJ, Rutgeerts P, Desmet VJ, Vantrappen G. Immunohistochemical
identification of lysozyme in pseudopyloric gland metaplasia in Crohn's disease. Hepatogastroenterology
1983; 30: 158-60.
14.Schirmer M, Franzosa EA, Lloyd-Price J, McIver LJ, Schwager R, Poon TW, et al. Dynamics
of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol
2018; 3: 337-46.
15.
Miyoshi J, Sofia MA, Pierre JF. The evidence for fungus in Crohn's disease pathogenesis.
Clin J Gastroenterol 2018; 11: 449-56.
16.Lavoie S, Conway KL, Lassen KG, Jijon HB, Pan H, Chun E, et al. The Crohn's disease
polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17
response. Elife 2019; doi: 10.7554/eLife.39982.
17.Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn's disease.
Gut 2008; 57: 1-4.
18.
Van Kruiningen HJ, Hayes AW, Colombel JF. Granulomas obstruct lymphatics in all layers
of the intestine in Crohn's disease. APMIS 2014; 122: 1125-9.
19.Gomollón F, Dignass A, Annese V, Magro Dias FJ, Rogler G, Lakatos PL, et al. 3rd European
Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016:
Part 1: Diagnosis and Medical Management. J Crohns Colitis 2017; 11: 3-25.
20.
Sura R, Colombel JF, Van Kruiningen HJ. Lymphatics, tertiary lymphoid organs and the
granulomas of Crohn's disease: an immunohistochemical study. Aliment Pharmacol Ther
2011; 8: 930-9.